Circulatinglong non-coding RNA FEZF1-AS1 and AFAP1-AS1 serve as potential diagnostic biomarkers for gastric cancer.

Wenwen Liu,Yi Li,Yan Zhang,Xianjuan Shen,Zhangyao Su,Lin Chen,Weihua Cai,Feng Wang,Shaoqing Ju

Pathology - Research and Practice（2020）

引用 12|浏览12

暂无评分

摘要

Our study indicated that serum FEZF1-AS1 and AFAP1-AS1 had better sensitivity and efficiency for the diagnosis of GC and the combination of the two lncRNAs might be used as a potential prognostic indicator in GC.

查看译文

关键词

Gastric cancer,Serum,Biomarkers,FEZF1-AS1,AFAP1-AS1

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要